| Nov-30-22 02:15AM |
What to know about the Alzheimer’s drug data coming out this weekMarketWatch |
| Nov-29-22 07:47AM |
What to know about the Alzheimer’s drug data coming out this weekMarketWatch |
| 09:05AM |
What to know about the Alzheimer’s drug data coming out this weekMarketWatch |
| Nov-29-22 07:39AM |
What to know about the Alzheimer’s drug data coming out this weekMarketWatch |
| Nov-25-22 06:20AM |
Is FlexShares International Quality Dividend ETF (IQDF) a Strong ETF Right Now?Zacks Investment Research |
| Nov-16-22 06:20AM |
Should You Invest in the Invesco S&P SmallCap Information Technology ETF (PSCT)?Zacks Investment Research |
| 01:58AM |
Roche gets FDA Emergency Use Authorization for Monkeypox virus testMarketWatch |
| Nov-16-22 01:00AM |
Roche receives U.S. FDA Emergency Use Authorization for its high-throughput test to detect monkeypox virus GlobeNewswire Inc. |
| Nov-15-22 07:14AM |
One Alzheimer's drug has failed, but investors are still betting on Biogen and Lilly treatmentsMarketWatch |
| Nov-14-22 02:34AM |
One Alzheimer's drug has failed, but investors are still betting on Biogen and Lilly treatments MarketWatch |
| 01:00AM |
[Ad hoc announcement pursuant to Art. 53 LR] Roche provides update on Phase III GRADUATE programme evaluating gantenerumab in early Alzheimer’s diseaseGlobeNewswire Inc. |
| Nov-09-22 01:00AM |
STRONG-HF study results demonstrate clear benefits for acute heart failure patientsGlobeNewswire Inc. |
| Nov-04-22 06:06AM |
Kellogg, Palo Alto Networks, Roku And Other Big Losers From ThursdayBenzinga |
| 04:41AM |
Why Greenhill Shares Climbed Around 25%; Here Are 100 Biggest Movers From YesterdayBenzinga |
| Nov-03-22 06:24AM |
Why Rogers Stock Tanked Again on ThursdayThe Motley Fool |
| 05:40AM |
Why Tupperware Brands Shares Dipped Around 42%; Here Are 89 Biggest Movers From YesterdayBenzinga |
| Nov-02-22 03:03AM |
Why Rogers Stock Crashed Hard TodayThe Motley Fool |
| 02:25AM |
Dow Jumps Over 200 Points After Fed Raises Rates By 75 Basis Points.Benzinga |
| Nov-02-22 01:28AM |
Why Benefitfocus Shares Are Trading Higher By Around 48%? Here Are 64 Stocks Moving In Wednesday's Mid-Day SessionBenzinga |
| 12:00PM |
Nasdaq Dips 100 Points; Crude Oil Rises SharplyBenzinga |
| Nov-02-22 11:33AM |
Rogers, Airbnb, Herbalife And Some Other Big Stocks Moving Lower On WednesdayBenzinga |
| 10:23AM |
US Stocks Open Lower; Dow Falls 100 PointsBenzinga |
| Nov-02-22 07:58AM |
Why Rogers Shares Are Trading Sharply Lower; Here Are 33 Stocks Moving PremarketBenzinga |
| Oct-26-22 11:45AM |
Early treatment with Roche's OCREVUS leads to reduced disease progression and healthcare costs; nine-year safety data reinforce favourable benefit-risk profile GlobeNewswire Inc. |
| Oct-24-22 01:00AM |
Roche receives FDA clearance for COVID-19 PCR test for use on cobas 6800/8800 SystemsGlobeNewswire Inc. |
| Oct-19-22 06:30AM |
Ready to Buy the Dip? This Healthcare Stock Is a Smart BuyThe Motley Fool |
| 01:00AM |
Roche to present new OCREVUS (ocrelizumab) data in multiple sclerosis and continued research into neuromyelitis optica spectrum disorder at ECTRIMS 2022GlobeNewswire Inc. |
| Oct-18-22 01:00AM |
[Annonce événementielle selon l’art. 53 RC] Roche affiche de solides résultats pour les neuf premiers mois de 2022GlobeNewswire Inc. |
| Oct-12-22 01:03AM |
Roche to introduce its next-generation portfolio of SARS-CoV-2 rapid antigen tests (“2.0”) under CE Mark for self-test and professional useGlobeNewswire Inc. |
| 01:00AM |
Positive new data for Roche’s Evrysdi in largest trial ever undertaken in patients with previously-treated spinal muscular atrophy (SMA)GlobeNewswire Inc. |
| Oct-11-22 01:00AM |
Roche launches PRAME (EPR20330) Antibody to identify PRAME protein expression in patients that may have melanoma GlobeNewswire Inc. |
| Oct-05-22 01:00AM |
Roche to present new data from its expanding neuromuscular disease portfolio at World Muscle Society 2022GlobeNewswire Inc. |
| Oct-04-22 01:00AM |
Roche receives FDA approval for first companion diagnostic to identify patients with HER2 low metastatic breast cancer eligible for ENHERTUGlobeNewswire Inc. |
| Oct-03-22 01:00AM |
[Ad hoc announcement pursuant to Art. 53 LR] Roche: Change in the Corporate Executive Committee in January 2023 GlobeNewswire Inc. |
| Sep-28-22 03:09AM |
Dow rebounds over 500 points in final hour of trade as Treasury and UK government bond yields fall after BOE interventionMarketWatch |
| 01:44AM |
Dow rebounds over 450 points as Treasury and UK government bond yields fall after BOE interventionMarketWatch |
| Sep-28-22 02:45AM |
Regulatory approval is next: Mizuho lifts Biogen to buy on news of Alzheimer's drug successMarketWatch |
| Sep-26-22 01:25AM |
Change in the Roche Board of DirectorsGlobeNewswire Inc. |
| Sep-19-22 02:01AM |
Roche’s vision-loss drug Vabysmo gets EU nodMarketWatch |
| 01:00AM |
European Commission approves Roche’s Vabysmo, the first bispecific antibody for the eye, for two leading causes of vision lossGlobeNewswire Inc. |
| Sep-13-22 06:20AM |
Should You Invest in the Invesco S&P SmallCap Information Technology ETF (PSCT)?Zacks Investment Research |
| Aug-23-22 01:00AM |
Roche launches a digital PCR system, a powerful new diagnostics platform in the fight against cancer and other diseasesGlobeNewswire Inc. |
| Aug-16-22 01:00AM |
FDA accepts supplemental Biologics License Application for Roche’s Polivy combination for people with previously untreated diffuse large B-cell lymphomaGlobeNewswire Inc. |
| Aug-15-22 01:00AM |
Roche launches new diagnostic test for the better understanding of immune response to SARS-CoV-2GlobeNewswire Inc. |
| Aug-12-22 01:00AM |
Roche announces U.S. FDA approval of Xofluza to treat influenza in children aged five years and olderGlobeNewswire Inc. |
| Aug-03-22 08:25AM |
Rogers Corp. (ROG) Misses Q2 Earnings EstimatesZacks Investment Research |
5.37%
+6.05
NameRogers Corporation
SectorTechnology (860)
IndustryElectronic Components (51)
Web
Phone480-917-6000
Employee3,400
Twitter
@Rogers_Corp
SEC filings
Latest SEC Filings
Address2225 West Chandler Boulevard, Chandler, AZ, United States (85224)